In this review, we collate and summarize the above evidence on TTC3 and its regulation of the protein degradation processes in cognitive impairment; then, we try to elucidate the important role of TTC3 in PQC and its potential as a therapeutic target approach to reduce cognitive decline (Fig. 1). The gene discussed is TTC3; the disease is Cognitive impairment.